Prostate Cancer Clinical Trial
Official title:
MAPS (Men After Prostate Surgery) : Conservative Treatment for Men With Urinary Incontinence After Prostate Surgery; Multicentre Randomised Controlled Trial of Pelvic Floor Muscle Training and Biofeedback [MAPS]
RATIONALE: Personalized training by a health professional may improve urinary incontinence.
It is not yet known whether pelvic floor muscle training and biofeedback are more effective
than standard therapy in improving urinary continence after radical prostatectomy or
transurethral resection of the prostate.
PURPOSE: This randomized phase III trial is studying pelvic floor muscle training and
biofeedback to see how well it works compared with standard therapy in men who have
undergone radical prostatectomy or transurethral resection.
OBJECTIVES:
- To establish whether conservative physical treatment delivered personally by a trained
health professional results in better urinary and other outcomes compared with standard
management in men who are incontinence after prostate surgery.
OUTLINE: This is a multicenter study. Patients are stratified according to type of operation
(radical prostatectomy vs transurethral resection of prostate). Patients are randomized to 1
of 2 treatment arms.
- Arm I (intervention group): At 6 weeks after surgery, patients undergo an assessment of
their symptoms by a physiotherapist or continence nurse. All patients are taught pelvic
floor muscle training and men with urgency or urge incontinence are also taught bladder
training. Pelvic floor training consists of 3 maximum pelvic floor contractions in 3
positions (standing, sitting, and lying down) twice a day, lifting of the pelvic floor
while walking, tightening of the pelvic muscles before activities, and tightening of
the pelvic muscles after urinating to squeeze out any last drops. The strength of the
pelvic floor contractions is monitored by biofeedback involving digital anal assessment
and relaying the information back to men in order that they know when they are
performing contractions correctly and to inform them when they are increasing the
strength or duration of their contractions. Therapists may use machine-mediated
biofeedback with an anal biofeedback probe at their discretion in addition to digital
anal assessment. Bladder training consists of gradually delaying urination by pelvic
floor muscle contraction and distracting activities to teach the bladder to hold
increasing volumes of urine. Patients also receive a customized Pelvic Floor Exercise
Booklet describing pelvic floor muscle training in addition to a customized Lifestyle
Advice Booklet giving general lifestyle advice. Patients have reinforcement sessions at
approximately 2, 6, and 12 weeks after the first appointment.
- Arm II (control group): Patients receive a customized Lifestyle Advice Booklet
containing supportive lifestyle advice only (without reference to pelvic floor muscle
training) by mail following randomization. Patients do not receive formal assessment or
treatment but will be able to access usual care and routine NHS services if they feel
they need help, including written advice if this is part of routine hospital care.
All patients keep a urinary diary at 3, 6, 9, and 12 months that includes frequency of
urination (day and night), daily episodes of incontinence and quantity of loss, daily use of
pads, and the need to change clothing or bedding. A Health Care Utilization Questionnaire
will be obtained at 3 and 9 months. Additional questionnaires are obtained at baseline and 6
and 12 months.
The use of NHS services, pads, and practice of pelvic floor muscle training is documented in
both groups using information from questionnaires and Urinary Diaries.
Six months after the last patient has been recruited, a check for Scottish men only is
performed to compare self-reported operations, diagnoses, and hospital admissions with
centrally collected data to validate a proportion of the data.
After completion of study treatment, patients are followed at 6 and 12 months.
;
Allocation: Randomized, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |